Warning letter
Nova-Tech Inc.: warning letter of Feb 25, 2000
FDA warning letter UCM068156 · Kansas City District Office
Key facts
| Reference number | UCM068156 |
|---|---|
| Company | Nova-Tech Inc. |
| Subject | Good Manufacturing Practices Violation/Finished Pharmaceuticals |
| Issue date | Feb 25, 2000 |
| Posted date | Feb 25, 2000 |
| Issuing office | Kansas City District Office |
| Product type | Drugs |
| CFR sections cited | 21, 211, 211.42, 211.182, 211.100(a), 211.113(b) |
| Country | 3 |
| Inspection city | Grand Island |
| Inspection ZIP | 68801-8904 |
| Inspection start date | Dec 7, 1999 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: